A private artificial intelligence company specializing in AI for drug discovery and development.
2 AI-extracted insights from 2 sources — podcasts, YouTube channels, and X/Twitter accounts.
Not enough scored insights about Insilico Medicine in the last 30 days yet.
The 2 sources with the most insights about Insilico Medicine on Kazuha.
AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.
Has 28 AI-discovered drugs in its pipeline and is showing success in clinical trial phases through AI optimization.
Highlighted as a prime example of a company successfully applying AI to a specific, high-value industry (drug discovery), which can dramatically speed up clinical trials.
Has 28 AI-discovered drugs in its pipeline and is showing success in clinical trial phases through AI optimization.
Highlighted as a prime example of a company successfully applying AI to a specific, high-value industry (drug discovery), which can dramatically speed up clinical trials.
Other assets that creators frequently mention in the same content as Insilico Medicine.
The most active sources covering Insilico Medicine (INSILICO_PRIVATE) on Kazuha are @peterdiamandis, PHD Ventures. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.
Kazuha has indexed 2 AI-extracted insights about Insilico Medicine (INSILICO_PRIVATE) from 2 different sources. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.
Creators covering Insilico Medicine (INSILICO_PRIVATE) most frequently also discuss NVDA, LLY, PRIVATE, AMZN, PRE-IPO. See the "Discussed alongside" section above for full asset pages.